Posted: 12/17/2024 03:13 pm
In contrast, in 2021, Bruce S. Rosenbloom, the Former Chief Financial Officer, had a total compensation of $784,689, which included a salary of $336,600, a modest bonus of $1,200, substantial stock awards of $311,220, and all other compensation amounting to $135,669^2. The predominance of stock awards in Rosenbloom's compensation highlights the emphasis on performance-based incentives during that period.
Menderes Akdag’s tenure as Chief Executive Officer and President saw even higher compensation figures. In 2021, Akdag's compensation peaked at $2,194,586, with significant portions allocated to stock awards at $1,179,360 and additional miscellaneous compensations totaling $395,301^3. This trend reflects the board's intent to align executive rewards with shareholder value through stock incentives. Prior to that, in 2020, Akdag’s total pay amounted to $1,303,460, again marked by considerable stock awards of $639,200^4.
The financial framework of executive compensation is intertwined with PetMed Express’s stock performance. As of the latest data, PETS stock trades at $5.58, experiencing a 2.1978% increase^5. Despite negative earnings per share at -0.06 and a concerning negative price-to-earnings ratio of -93, the stock price has demonstrated resilience with a 50-day average price of $4.663 and a 200-day average of $4.18525. It highlights investors’ cautious optimism in a challenging economic environment, reflected also in a market capitalization of $115.3 million and a price range that saw a yearly low of $2.9 and a high of $7.79.
PetMed Express’s focus on stock-based compensation has aimed at fostering long-term growth aligning executive interests with those of shareholders—a crucial strategy amid evolving market dynamics and competitive pressures in the retail drug sector.
---
1. [Mathew N. Hulett, Former Chief Executive Officer and President, 2024 SEC Filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013024000050/0001040130-24-000050-index.htm)
2. [Bruce S. Rosenbloom, Former Chief Financial Officer, 2021 SEC Filing](https://www.sec.gov/Archives/edgar/data/1040130/000104013023000044/0001040130-23-000044-index.htm)
3. [Menderes Akdag, Chief Executive Officer and President, 2021 SEC Filing](https://www.sec.gov/Archives/edgar/data/1040130/000143774921015104/0001437749-21-015104-index.htm)
4. [Menderes Akdag, Chief Executive Officer and President, 2020 SEC Filing](https://www.sec.gov/Archives/edgar/data/1040130/000143774920013455/0001437749-20-013455-index.htm)
5. Current PETS Stock Information as of Timestamp 1734469201
